1-2 of 2
Tomasz Burzykowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant as Future for Drug Development in Breast Cancer—Letter

Marc Buyse, Tomasz Burzykowski, Everardo D. Saad
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 268.
https://doi.org/10.1158/1078-0432.CCR-15-1047
Published: 03 January 2016
View article titled, Neoadjuvant as Future for Drug Development in Breast Cancer—Letter
Open the PDF for Neoadjuvant as Future for Drug Development in Breast Cancer—Letter in another window
Journal Articles

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

Howard M. Stern, Humphrey Gardner, Tomasz Burzykowski, Wafaa Elatre, Carol O'Brien, Mark R. Lackner, Gary A. Pestano, Angela Santiago, Ivonne Villalobos, Wolfgang Eiermann, Tadeusz Pienkowski, Miguel Martin, Nicholas Robert, John Crown, Paolo Nuciforo, Valerie Bee, John Mackey, Dennis J. Slamon, Michael F. Press
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (9): 2065–2074.
https://doi.org/10.1158/1078-0432.CCR-14-2993
Published: 30 April 2015
View article titled, PTEN Loss Is Associated with Worse Outcome in <em>HER2</em>-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Open the PDF for PTEN Loss Is Associated with Worse Outcome in <em>HER2</em>-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance in another window
Includes: Supplementary data